The human P2X7 receptor alters microglial morphology and cytokine secretion following immunomodulation

被引:7
作者
von Muecke-Heim, Iven-Alex [1 ]
Martin, Jana [1 ]
Uhr, Manfred [2 ]
Ries, Clemens [1 ]
Deussing, Jan M. M. [1 ]
机构
[1] Max Planck Inst Psychiat, Mol Neurogenet, Munich, Germany
[2] Max Planck Inst Psychiat, Core Unit Analyt & Mass Spectrometry, Munich, Germany
关键词
mouse model; cell culture; immunomodulation; knockout (KO) mice; microglia; cytokine secretion; MAJOR DEPRESSIVE DISORDER; PSYCHOLOGICAL STRESS; P2X(7) RECEPTOR; INFLAMMATION; METAANALYSIS; ASSOCIATION; ADENOSINE; RELEASE; CELLS;
D O I
10.3389/fphar.2023.1148190
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: In recent years, purinergic signaling via the P2X7 receptor (P2X7R) on microglia has repeatedly been implicated in depression genesis. However, it remains unclear which role the human P2X7R (hP2X7R) plays in regulating both microglia morphology and cytokine secretion upon different environmental and immune stimuli, respectively. Methods: For this purpose, we used primary microglial cultures derived from a humanized microglia-specific conditional P2X7R knockout mouse line to emulate different gene-environment interactions between microglial hP2X7R and molecular proxies of psychosocial and pathogen-derived immune stimuli. Microglial cultures were subjected to treatments with the agonists 2'(3')-O-(4-benzoylbenzoyl)-ATP (BzATP) and lipopolysaccharides (LPS) combined with specific P2X7R antagonists (JNJ-47965567, A-804598). Results: Morphotyping revealed overall high baseline activation due to the in vitro conditions. Both BzATP and LPS + BzATP treatment increased round/ameboid microglia and decreased polarized and ramified morphotypes. This effect was stronger in hP2X7R-proficient (CTRL) compared to knockout (KO) microglia. Aptly, we found antagonism with JNJ-4796556 and A-804598 to reduce round/ameboid microglia and increase complex morphologies only in CTRL but not KO microglia. Single cell shape descriptor analysis confirmed the morphotyping results. Compared to KO microglia, hP2X7R-targeted stimulation in CTRLs led to a more pronounced increase in microglial roundness and circularity along with an overall higher decrease in aspect ratio and shape complexity. JNJ-4796556 and A-804598, on the other hand, led to opposite dynamics. In KO microglia, similar trends were observed, yet the magnitude of responses was much smaller. Parallel assessment of 10 cytokines demonstrated the proinflammatory properties of hP2X7R. Following LPS + BzATP stimulation, IL-1 beta, IL-6, and TNFa levels were found to be higher and IL-4 levels lower in CTRL than in KO cultures. Vice versa, hP2X7R antagonists reduced proinflammatory cytokine levels and increased IL-4 secretion. Discussion: Taken together, our results help disentangle the complex function of microglial hP2X7R downstream of various immune stimuli. In addition, this is the first study in a humanized, microglia-specific in vitro model identifying a so far unknown potential link between microglial hP2X7R function and IL-27 levels.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain
    Choi, Hyun B.
    Ryu, Jae K.
    Kim, Seung U.
    McLarnon, James G.
    [J]. JOURNAL OF NEUROSCIENCE, 2007, 27 (18) : 4957 - 4968
  • [42] Selective P2X7 receptor antagonists for chronic inflammation and pain
    William A. Carroll
    Diana Donnelly-Roberts
    Michael F. Jarvis
    [J]. Purinergic Signalling, 2009, 5
  • [43] P2X7 Receptor Upregulation in Huntington's Disease Brains
    Olla, Ivana
    Santos-Galindo, Maria
    Elorza, Ainara
    Lucas, Jose J.
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [44] Purinergic P2X7 receptor as a potential therapeutic target in depression
    Qi, Wang
    Jin, Xiang
    Guan, Wei
    [J]. BIOCHEMICAL PHARMACOLOGY, 2024, 219
  • [45] The Role of the P2X7 Receptor in the Retina: Cell Signalling and Dysfunction
    Vessey, Kirstan A.
    Jobling, Andrew I.
    Greferath, Ursula
    Fletcher, Erica L.
    [J]. RETINAL DEGENERATIVE DISEASES, 2012, 723 : 813 - 819
  • [46] The role of polycyclic frameworks in modulating P2X7 receptor function
    Callis, Timothy B.
    Reekie, Tristan A.
    O'Brien-Brown, James
    Wong, Erick C. N.
    Werry, Eryn L.
    Elias, Nabiha
    Jorgensen, William T.
    Tsanaktsidis, John
    Rendina, Louis M.
    Kassiou, Michael
    [J]. TETRAHEDRON, 2018, 74 (12) : 1207 - 1219
  • [47] Could P2X7 receptor be a potencial target in neonatal sepsis?
    Fialho, Sales
    Trieu-Cuot, Patrick
    Ferreira, Paula
    Oliveira, Laura
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
  • [48] Selective P2X7 receptor antagonists for chronic inflammation and pain
    Carroll, William A.
    Donnelly-Roberts, Diana
    Jarvis, Michael F.
    [J]. PURINERGIC SIGNALLING, 2009, 5 (01) : 63 - 73
  • [49] The P2X7 purinergic receptor: from physiology to neurological disorders
    Skaper, Stephen D.
    Debetto, Patrizia
    Giusti, Pietro
    [J]. FASEB JOURNAL, 2010, 24 (02) : 337 - 345
  • [50] Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis
    Amadio, Susanna
    Parisi, Chiara
    Piras, Eleonora
    Fabbrizio, Paola
    Apolloni, Savina
    Montilli, Cinzia
    Luchetti, Sabina
    Ruggieri, Serena
    Gasperini, Claudio
    Laghi-Pasini, Franco
    Battistini, Luca
    Volonte, Cinzia
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8